2009
DOI: 10.1111/j.1600-6143.2008.02500.x
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Donor Age and Cell Senescence on Kidney Allograft Survival

Abstract: The biological processes responsible for somatic cell senescence contribute to organ aging and progression of chronic diseases, and this may contribute to kidney transplant outcomes. We examined the effect of pre-existing donor aging on the performance of kidney transplants, comparing mouse kidney isografts and allografts from old versus young donors. Before transplantation, old kidneys were histologically normal, but displayed an increased expression of senescence marker p16 INK4a . Old allografts at day 7 s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
81
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 91 publications
(84 citation statements)
references
References 27 publications
3
81
0
Order By: Relevance
“…Human transplant biopsy studies have shown that periand post-transplantation stresses (such as ischemia-reperfusion injury, 24,28,29 acute rejection, 30 or hypertension 31 ) lead to an increased p16…”
Section: Resultsmentioning
confidence: 99%
“…Human transplant biopsy studies have shown that periand post-transplantation stresses (such as ischemia-reperfusion injury, 24,28,29 acute rejection, 30 or hypertension 31 ) lead to an increased p16…”
Section: Resultsmentioning
confidence: 99%
“…In addition, the kidney allograft from old mice is highly susceptible to transplant stress (20). Moreover, both the function and integrity of epithelial barriers decrease with age (21).…”
Section: Discussionmentioning
confidence: 99%
“…A reliable readout that identifies senescent cells would facilitate high-throughput screens as well as allow quantification of aging in various animal models. Most importantly, therapeutic techniques would benefit from robust markers to enable removal of senescent cells from tissues (such as blood filtering, Figure 3), stem cell preparations from aged autologous donors (Melk et al, 2009) and identification of replicative exhaustion in stem cell expansions. One example of how such markers could be used is a strategy using selectively-lytic viruses, which are already used in oncology (Elsedawy and Russell, 2013).…”
Section: The Challenge and Benefits Of Finding Robust Cellular Senescmentioning
confidence: 99%